India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC
The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.